India tops WHO’s chart...
India aims at eliminating TB by 2025, which means bringing down incidence to less than one case per lakh population. The current incidence in India is 211 cases per lakh, according to the WHO report.
The WHO TB report 2017 further estimates that 1,47,000 patients in India were grappling with Multidrug resistant TB - that in which the first line drugs of Rifampacin, Isoniazid, Ethambutol and Pyrazinamide do not work. However, the Indian government has records of only 37,258 MDR-TB patients, which means that over a lakh drug-resistant patients are going untreated.
Ten countries including India accounted for 75 per cent of the incidence-treatment enrolment gap for drugresistant TB. India and China accounted for 39 per cent of the global gap, says the report.
Despite the National Strategic Plan of India aiming to make Bedaquiline, a drug used to treat MDR-TB available at 140 sites, it is currently given to only a handful, only 728 people in all of India, in six sites are receiving the life-saving drug. The gap in availability of the drug to needy patients is huge.